*Source: Pediatric Dermatology Research Alliance (PeDRA).
View this sponsored webinar hosted in partnership with Abeona Therapeutics on cutting edge clinical development updates towards the treatment of epidermolysis bullosa. This webinar features presentations from Jean Tang, MD, PhD (Professor of Dermatology, Stanford University Medical Center and Principal Investigator, EB-101 pivotal Phase 3 VIITAL study) and Michael Amoroso (Chief Commercial Officer, Abeona) and moderated discussion. Recorded live on November 12, 2020.
Oradores
MD, PhD
Jean Tang
Profesor de Dermatología, Stanford University Medical Center e investigador principal, ensayo EB-101 fase fundamental 3 VIITAL
Michael Amoroso
Director comercial, Abeona
